12:03 PM 4/4/2012
via First Time: News on 4/4/12
via »Puerto Rico by caribnews on 4/3/12
SAN JUAN, Puerto Rico (International News Service) The Supreme Court today stopped the count and recount law on the primaries, just before they could be given a hearing on a writ of mandamus who submitted the Election Commission (EC) to the New Progressive Party (PNP) to return to the work tables.
The highest court halted the process locally imposed by the EEC for clarification of doubts about alleged irregularities in the counting of votes, cast lists and other matters, to receive a request from the PNP.
The judge who attended the hearing in the Court of San Juan, Georgina Candal, informed the parties that the Supreme Court stopped the case for analyzing an application for certification to be that forum who asks.
The PNP required to open the lists of votes of his party with the Democratic People's Party were included to check for votes from people who did not attend the primaries really.
Also requests the scrutiny and recount begins in precinct 1 and not in the cross sectional area that stopped the process when the EEC took over last week.
The highest court halted the process locally imposed by the EEC for clarification of doubts about alleged irregularities in the counting of votes, cast lists and other matters, to receive a request from the PNP.
The judge who attended the hearing in the Court of San Juan, Georgina Candal, informed the parties that the Supreme Court stopped the case for analyzing an application for certification to be that forum who asks.
The PNP required to open the lists of votes of his party with the Democratic People's Party were included to check for votes from people who did not attend the primaries really.
Also requests the scrutiny and recount begins in precinct 1 and not in the cross sectional area that stopped the process when the EEC took over last week.
via First Time: The Latest on 4/4/12
via The New Day: Policy on 4/4/12
via The New Day: Policy on 4/4/12
via Twitter / ElNuevoDia on 4/3/12
ElNuevoDia: Mitt Romney wins # # Wisconsin, Maryland and # washingtondc # http://t.co/vjzSbIh5
via Twitter / ElNuevoDia on 4/4/12
ElNuevoDia: In Focus: Court takes the case of elementary Judge of First Instance and stops counting. http://t.co/rc269ZPl ...
via Twitter / ElNuevoDia on 4/3/12
ElNuevoDia: Trio Sentenced to provide armed security kilos of coca http://t.co/KmABZ0CV
via »Puerto Rico by caribnews on 4/3/12
By: Leila A. Andreu Cuevas / Center for Investigative Journalism
The incidence of thyroid cancer in Puerto Rico has doubled in recent years, making this type of cancer in the fastest growing in the island over the past two decades. The highest incidence is among women, although the mortality rate remains low, according to a study by the School of Medicine, University of Puerto Rico (UPR).
The study in Puerto Rico found that the incidence of thyroid cancer, which includes a small number of malignant tumors in the thyroid glands, increased significantly from 1985 to 2004, mainly the papillary type, although mortality remains low.
The results of the study
The incidence rate of this cancer increased from 3.0 to 7.0 per 100,000 (increase of 2.3 times), with an annual percentage change of 5.3% during the period.
The incidence was higher among women (from 4.7 in 1985 to 10.5 per 100,000 in 2004) compared to men (from 1.1 in 1985 to 3.0 per 100,000 men in 2004).
The researchers noted that this upward trend was largely due to an increase in the incidence of papillary thyroid cancer, type increased from 2.4 to 6.0 per 100,000 population (more than twice).
Moreover, the mortality rate remains low (0.4 in 1985 and 0.3 per 100,000 in 2004), with no significant change of less than 0.05 or -1.1%.
Puerto Rico with the same tendency of U.S.
The American Thyroid Association (ATA for short) published in Clinical Thyroidology newsletter, in March 2011 , that "thyroid carcinoma is the fastest growing incidence of all cancers in the database of the National Institute Cancer ".
The study reported by the ATA newsletter, using the case register of the National Cancer Institute (DT Hughes, Haymart MR, Miller BS, PG Gauger and GM Doherty) found that papillary thyroid cancer most common in the United States is Now the micro carcinoma in patients over 45 years and its incidence increased from 3.85 cases per 100,000 population in 1975 to 11.99 per 100,000 in 2007.
However, states that "the mortality has decreased slightly, from 0.55 deaths per 100,000 in 1975 to 0.47 per 100,000 in 2007, suggesting there may be an increase in the proportion of diagnoses of tumors of low risk."
The study of cases from 1974 to 2006 in the U.S. showed that the most common age to be diagnosed with papillary thyroid cancer patients moved their 30 patients of 40-50 years.
Until 1999, most cases occurred in patients younger than 45 years after that year papillary thyroid cancer became more common among those over 45.
They also noted that due to the increase in older population, most patients diagnosed with papillary cancer now have more than 45 years when the late 1980's were mostly twenty-something or early 30.
The database of the Institute is known as "Surveillance, Epidemiology, and End Results" or SEER, and was designed to be a sample of more than 28% of the U.S. population, with representation by sex, race and socioeconomic level.
Ethnic differences in our favor
The study " Ethnic patterns of thyroid Cancer Incidence in the United States, 1973-1981 "(Spitz MR, Sider JG, Katz RL, Pollack ES, Newell GR) of the MD Anderson Cancer Center, University of Texas found that" variations in the risk of thyroid cancer according to ethnicity and geographic residence may reflect socioeconomic influences or a local environment, including the possibility of a carcinogen in the lava. " This last comment referred to the high incidence in Hawaii, across all ethnic groups.
This study, published in 1988 on ethnic patterns in the incidence found that "compared with white men and women, Hispanics from Puerto Rico and blacks had a significantly lower rate of thyroid cancer. Hispanic men in New Mexico and Chinese, Japanese, Hawaiian and Filipino women and men had significantly higher rates. Among residents of Hawaii in particular, no matter what ethnicity they were, had a high incidence. "
Continue the clinical studies
Thyroid cancer, like many others, is the subject of several scientific studies in leading universities and medical world. These have confirmed the benefits of combining surgery with radioactive iodine therapy and thyroid hormone, resulting in a higher rate of healing, fewer recurrences and more years.
The most recent American Cancer Society (SAC) reports that progress has been made in studies of genetics, treatment, radioactive iodine therapy, chemotherapy and targeted therapies for the disease.
The field of genetics, have found that there is a medullary thyroid cancer is hereditary family can now identify carriers of a "proto-oncogene RET" to remove abnormal gland and prevent disease develops. This gene is important in promoting growth and cell division.
Researchers are also optimistic, according to the Society, with the progress made to meet the abnormal genes that cause hereditary or sporadic cancer, including papillary, which will lead them to develop better treatments.
Thyroid cancer usually responds poorly to chemotherapy, but is still working on new drugs specific for malignant cells, rather than the standard treatment that attacks the entire human system. There are several classes of these drugs currently available and other clinical studies.
For more information about thyroid cancer see: American Thyroid Association , the American Cancer Society or National Cancer Institute , which has pages in Spanish. If you want to participate in clinical studies can investigate the registration of all studies here .
For more information on the study of Puerto Rico, please write to ramirezvick@onelinkpr.net .
The incidence of thyroid cancer in Puerto Rico has doubled in recent years, making this type of cancer in the fastest growing in the island over the past two decades. The highest incidence is among women, although the mortality rate remains low, according to a study by the School of Medicine, University of Puerto Rico (UPR).
Overall, the incidence of many cancers have decreased since 1999, according to the Communicable Disease Centre (CDC for its acronym in English). However, there are other cancers whose incidence increased from 1999 to 2008 such as pancreas, kidney, thyroid, liver and melanoma.
The investigators of the Section of Endocrinology, Department of Medicine Medical Sciences Campus of the UPR ( Ramirez-Vick M , Nieves-Rodriguez M , Lugaro-Gomez A , Perez-Irizarry J .) published "Increasing Incidence of thyroid cancer in Puerto Rico, 1985-2004 "using data from the Central Cancer Registry of Puerto Rico to conduct a retrospective study of patients diagnosed with evil between 1 January 1985 and December 31, 2004. The study in Puerto Rico found that the incidence of thyroid cancer, which includes a small number of malignant tumors in the thyroid glands, increased significantly from 1985 to 2004, mainly the papillary type, although mortality remains low.
The results of the study
The incidence rate of this cancer increased from 3.0 to 7.0 per 100,000 (increase of 2.3 times), with an annual percentage change of 5.3% during the period.
The incidence was higher among women (from 4.7 in 1985 to 10.5 per 100,000 in 2004) compared to men (from 1.1 in 1985 to 3.0 per 100,000 men in 2004).
The researchers noted that this upward trend was largely due to an increase in the incidence of papillary thyroid cancer, type increased from 2.4 to 6.0 per 100,000 population (more than twice).
Moreover, the mortality rate remains low (0.4 in 1985 and 0.3 per 100,000 in 2004), with no significant change of less than 0.05 or -1.1%.
Puerto Rico with the same tendency of U.S.
The American Thyroid Association (ATA for short) published in Clinical Thyroidology newsletter, in March 2011 , that "thyroid carcinoma is the fastest growing incidence of all cancers in the database of the National Institute Cancer ".
The study reported by the ATA newsletter, using the case register of the National Cancer Institute (DT Hughes, Haymart MR, Miller BS, PG Gauger and GM Doherty) found that papillary thyroid cancer most common in the United States is Now the micro carcinoma in patients over 45 years and its incidence increased from 3.85 cases per 100,000 population in 1975 to 11.99 per 100,000 in 2007.
However, states that "the mortality has decreased slightly, from 0.55 deaths per 100,000 in 1975 to 0.47 per 100,000 in 2007, suggesting there may be an increase in the proportion of diagnoses of tumors of low risk."
The study of cases from 1974 to 2006 in the U.S. showed that the most common age to be diagnosed with papillary thyroid cancer patients moved their 30 patients of 40-50 years.
Until 1999, most cases occurred in patients younger than 45 years after that year papillary thyroid cancer became more common among those over 45.
They also noted that due to the increase in older population, most patients diagnosed with papillary cancer now have more than 45 years when the late 1980's were mostly twenty-something or early 30.
The database of the Institute is known as "Surveillance, Epidemiology, and End Results" or SEER, and was designed to be a sample of more than 28% of the U.S. population, with representation by sex, race and socioeconomic level.
Ethnic differences in our favor
The study " Ethnic patterns of thyroid Cancer Incidence in the United States, 1973-1981 "(Spitz MR, Sider JG, Katz RL, Pollack ES, Newell GR) of the MD Anderson Cancer Center, University of Texas found that" variations in the risk of thyroid cancer according to ethnicity and geographic residence may reflect socioeconomic influences or a local environment, including the possibility of a carcinogen in the lava. " This last comment referred to the high incidence in Hawaii, across all ethnic groups.
This study, published in 1988 on ethnic patterns in the incidence found that "compared with white men and women, Hispanics from Puerto Rico and blacks had a significantly lower rate of thyroid cancer. Hispanic men in New Mexico and Chinese, Japanese, Hawaiian and Filipino women and men had significantly higher rates. Among residents of Hawaii in particular, no matter what ethnicity they were, had a high incidence. "
Continue the clinical studies
Thyroid cancer, like many others, is the subject of several scientific studies in leading universities and medical world. These have confirmed the benefits of combining surgery with radioactive iodine therapy and thyroid hormone, resulting in a higher rate of healing, fewer recurrences and more years.
The most recent American Cancer Society (SAC) reports that progress has been made in studies of genetics, treatment, radioactive iodine therapy, chemotherapy and targeted therapies for the disease.
The field of genetics, have found that there is a medullary thyroid cancer is hereditary family can now identify carriers of a "proto-oncogene RET" to remove abnormal gland and prevent disease develops. This gene is important in promoting growth and cell division.
Researchers are also optimistic, according to the Society, with the progress made to meet the abnormal genes that cause hereditary or sporadic cancer, including papillary, which will lead them to develop better treatments.
Thyroid cancer usually responds poorly to chemotherapy, but is still working on new drugs specific for malignant cells, rather than the standard treatment that attacks the entire human system. There are several classes of these drugs currently available and other clinical studies.
For more information about thyroid cancer see: American Thyroid Association , the American Cancer Society or National Cancer Institute , which has pages in Spanish. If you want to participate in clinical studies can investigate the registration of all studies here .
For more information on the study of Puerto Rico, please write to ramirezvick@onelinkpr.net .
Original Text:
Show alternative translations